News

‘There is nothing you could have done, because this was my decision to go to Switzerland and be in peace… I can’t keep going and get older and older without my son.’ Judith Hamilton learnt ...
The university claims using the logo in the scene "simply goes too far ... “The White Lotus not only uses our brand without permission,” he continued, “but in our view uses it on imagery ...
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...
Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...
NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...
“Ghost guns are the gun industry’s way of skirting commonsense gun laws and arming dangerous people without background checks,” said David Pucino, legal director and deputy chief counsel of ...
40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...